We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Acceptability of Zinc-fortified Lipid-based Nutrient Supplements

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00944814
Recruitment Status : Completed
First Posted : July 23, 2009
Last Update Posted : February 23, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study is to assess the acceptability of the two lipid-based nutrient supplement (LNS) formulations containing no zinc and a high amount of zinc (10 mg zinc / 20 g dose of LNS). The hypothesis is that both products will be equally accepted by children and mothers.

Condition or disease Intervention/treatment
Malnutrition Dietary Supplement: LNS with zinc Dietary Supplement: LNS without zinc

Detailed Description:
We plan to conduct a series of acceptability studies to: 1) assess the amounts of zinc-free and high-zinc LNS consumed by children during direct observation, 2) compare their mothers' sensory assessments of the respective products, and 3) review maternal reports of their child feeding experiences during more prolonged home feeding trials.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 36 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Assessment of the Acceptability of Zinc-fortified Lipid Based Nutrient (LNS) Prepared for Young Burkinabe Children
Study Start Date : July 2009
Primary Completion Date : August 2009
Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: LNS with zinc
LNS containing 10 mg zinc per 20 g dose of LNS
Dietary Supplement: LNS with zinc
Lipid-based nutrient supplement (LNS) containing 10 mg zinc/20 g LNS dose
Other Name: Nutriset lipid-based nutrient supplement with zinc
Placebo Comparator: LNS without zinc
LNS containing no zinc
Dietary Supplement: LNS without zinc
LNS containing no zinc
Other Name: Nutriset lipid-based nutrient supplement without zinc

Outcome Measures

Primary Outcome Measures :
  1. Amount of each type of LNS formulation consumed by young children [ Time Frame: 3 days ]
  2. Preference and detection of differences between LNS formulations among mothers [ Time Frame: 3 days ]
  3. Acceptability of feeding LNS to young children at home [ Time Frame: 2 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   9 Months to 15 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Currently breast-feeding and consuming complementary foods for at least 30 d

Exclusion Criteria:

  • Height-for-age and weight-for height Z-scores <-3 with respect to WHO growth standards
  • Edema
  • Diarrhea and other diseases that could interfere with food intake
  • Severe systemic illness
  • History of peanut allergy
  • History of anaphylaxis/serious allergic reaction

Infants meeting these criteria and their mother's will be invited to participate

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00944814

Burkina Faso
Institut de Recherche en Sciences de la Santé
Bobo-Dioulasso, Burkina Faso
Sponsors and Collaborators
University of California, Davis
Université Polytechnique de Bobo-Dioulasso
Helen Keller International
Bill and Melinda Gates Foundation
Principal Investigator: Kenneth H. Brown, MD University of California, Davis
More Information

Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT00944814     History of Changes
Other Study ID Numbers: 200917273
First Posted: July 23, 2009    Key Record Dates
Last Update Posted: February 23, 2017
Last Verified: February 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of California, Davis:
Lipid-based nutrient supplement
Prevention of malnutrition
Prevention of micronutrient deficiencies

Additional relevant MeSH terms:
Nutrition Disorders
Trace Elements
Growth Substances
Physiological Effects of Drugs